Skip to main content

Kappa Opioid Receptors on Three Related Thymoma Cell Lines

Differences in Receptor-Effector Coupling

  • Chapter
The Brain Immune Axis and Substance Abuse

Abstract

The search for opioid binding sites on leukocytes has been difficult. The presence of opioid binding sites has been reported on human and murine leukocytes (1–3) as well as on some cell lines (4,5). However, in contrast to brain opioid receptors, these sites do not exhibit all of the classical opioid binding characteristics, such as stereoselectivity and high affinity for both alkaloids and peptides (6). In addition, agonist-induced functional responses have not been correlated with these binding sites. It seems likely that only a small population of leukocytes actually express opioid receptors, and possibly only under certain conditions. If this is the case, binding studies with mixed cell populations may not show a detectable signal-to-noise ratio, even when receptors are present.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. J. Madden, R. M. Donahoe, J. Zwemer-Collins, D. A. Shafer and A. Falek, Binding of naloxone to human T lymphocytes, Biochem. Pharmacol. 36: 4103–4109 (1987).

    Article  PubMed  CAS  Google Scholar 

  2. H. Ovadia, P. Nitsan and O. Abramsky, Characterization of opiate binding sites on membranes of rat lymphocytes,.J. Neuroimmunol. 21:93–102 (1989).

    Article  PubMed  CAS  Google Scholar 

  3. S. Roy, B.-L. Ge, S. Ramakrishnan, N. M. Lee and H. H. Loh, [3H]Morphine binding is enhanced by IL-1-stimulated thymocyte proliferation, FEBS Lett. 287: 93–96 (1991).

    Article  PubMed  CAS  Google Scholar 

  4. E. Fiorica and S. Spector, Opioid binding site in EL-4 thymoma cell line. Life Sci. 42:199–206 (1988).

    Article  PubMed  CAS  Google Scholar 

  5. D. J. J. Carr, B. R. DeCosta, C.-H. Kim, A. E. Jacobson, V. Guarcello, K. C. Rice and J. E. Blalock, Opioid receptors on cells of the immune system: evidence for δ- and K-classes, J. Endocrinol. 122:161–168 (1989).

    Article  PubMed  CAS  Google Scholar 

  6. N. E. S. Sibinga and A. Goldstein, Opioid peptides and opioid receptors in cells of the immune system, Ann. Rev. Immunol. 6:219–249 (1988).

    Article  CAS  Google Scholar 

  7. J. M. Bidlack, L. D. Saripalli and D. M. P. Lawrence, κ-Opioid binding sites on a murine lymphoma cell line, Eur. J. Pharmacol. 227:257–265 (1992).

    Article  PubMed  CAS  Google Scholar 

  8. D. M. P. Lawrence and J. M. Bidlack, The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein, J. Pharmacol. Exp. Ther 266:1678–1683 (1993).

    PubMed  CAS  Google Scholar 

  9. P. Ralph, Retention of lymphocyte characteristics by myelomas and θ+-lymphomas: sensitivity to cortisol and phytohemagglutinin, J. Immunol. 110:1470–1475 (1973).

    PubMed  CAS  Google Scholar 

  10. R. S. Zukin, M. Eghbali, D. Olive, E. M. Unterwald and A. Tempel, Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for κ1 and κ2 opioid receptors, Proc. Natl. Acad. Sci. U.S.A. 85:4061–4065 (1988).

    Article  PubMed  CAS  Google Scholar 

  11. J. A. Clark, L. Liu, M. Price, B. Hersh, M. Edelson and G. W. Pasternak, Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive κ1 subtypes and a novel κ3 subtype, J. Pharmacol. Exp. Ther 251:461–468 (1989).

    PubMed  CAS  Google Scholar 

  12. G. P. Brown, K. M. Standifer and G. W. Pasternak, Biochemical characterization of κ1 opiate binding sites in R1.1 thymoma cells, Soc. Neurosci. Abstr 19:1154 (1993).

    Google Scholar 

  13. D. M. P. Lawrence, D. B. Joseph and J. M. Bidlack, Kappa opioid receptors expressed on three related thymoma cell lines: differences in receptor-effector coupling, Biochem. Pharmacol. 49:81–89 (1995).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bidlack, J.M., Joseph, D.B., Lawrence, D.M.P. (1995). Kappa Opioid Receptors on Three Related Thymoma Cell Lines. In: Sharp, B.M., Eisenstein, T.K., Madden, J.J., Friedman, H. (eds) The Brain Immune Axis and Substance Abuse. Advances in Experimental Medicine and Biology, vol 373. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1951-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1951-5_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5801-5

  • Online ISBN: 978-1-4615-1951-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics